Annals of Emergency Medicine
Volume 54, Issue 3 , Pages 409-420 , September 2009

A Bacterial Cocaine Esterase Protects Against Cocaine-Induced Epileptogenic Activity and Lethality

Received 16 January 2008 ,Revised 12 September 2008 ,Accepted 23 September 2008.

References 

  1. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network 2003: interim national estimates of drug-related emergency department visits. December 2004. http://www.drugabuse.gov/infofacts/HospitalVisits.html. Accessed January 3, 2008.
  2. Di Maio VJM, Garriott JC. Four deaths due to intravenous injection of cocaine. Forensic Sci Int. 1978;12:119–125
  3. Tseng CC, Derlet RW, Stark LG, et al. Cocaine-induced respiratory depression in urethane-anesthetized rats: a possible mechanism of cocaine-induced death. Pharmacol Biochem Behav. 1991;39:625–633
  4. Tseng CC, Derlet RW, Albertson TE. Cocaine-induced respiratory depression and seizures are synergistic mechanisms of cocaine-induced death in rats. Ann Emerg Med. 1992;21:486–493
  5. Wilson KC, Saukkonen JJ. Acute respiratory failure from abused substances. J Intensive Care Med. 2004;19:183–193
  6. Zimmerman JL. Poisoning and overdoses in the intensive care unit: general and specific management issues. Crit Care Med. 2003;31:2794–2801
  7. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100:1040–1043
  8. Landry DW, Zhao K, Yang GXQ, et al. Antibody-catalyzed degradation of cocaine. Science. 1993;259:1899–1901
  9. Carroll FI, Howell LL, Kuhar MJ. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem. 1999;42:2721–2736
  10. Larsen NA, Turner JM, Stevens J, et al. Crystal structure of a bacterial cocaine esterase. Nat Struct Biol. 2002;9:17–21
  11. Mets B, Winger G, Cabrera C, et al. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc Natl Acad Sci U S A. 1998;95:10176–10181
  12. Deng SX, de Prada P, Landry DW. Anticocaine catalytic antibodies. J Immunol Methods. 2002;269:299–310
  13. Xie W, Altamirano CV, Bartels CF, et al. An improved cocaine hydrolase: the A328Y mutant of human butylcholinesterase is 4-fold more efficient. Mol Pharmacol. 1999;55:83–91
  14. Sun H, Shen ML, Pang YP, et al. Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. Proc Natl Acad Sci U S A. 2002;302:710–716
  15. Cooper ZD, Narasimhan D, Sunahara RK, et al. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol Pharmacol. 2006;70:1885–1891
  16. Turner JM, Larsen NA, Basran A, et al. Biochemical characterization and structural analysis of a highly proficient cocaine esterase. Biochemistry. 2002;41:12297–12307
  17. Ko MC, Bowen LD, Narasimhan D, et al. Cocaine esterase: interactions with cocaine and immune responses in mice. J Pharmacol Exp Ther. 2007;320:926–933
  18. Tseng CC, Derlet RW, Albertson TE. Acute cocaine toxicity: the effect of agents in non-seizure-induced death. Pharmacol Biochem Behav. 1993;46:61–65
  19. Hanson GR, Jensen M, Johnson M, et al. Distinct features of seizures induced by cocaine and amphetamine analogs. Eur J Pharmacol. 1999;377:167–173
  20. Kramer LD, Locke GE, Ogunyemi A, et al. Cocaine-related seizures in adults. Am J Drug Alcohol Abuse. 1990;16:307–317
  21. Pascual-Leone A, Dhuna A, Altafullah I, et al. Cocaine-induced seizures. Neurology. 1990;40:404–407
  22. Dhuna A, Pascual-Leone A, Langendorf F. Chronic, habitual cocaine abuse and kindling-induced epilepsy: a case report. Epilepsia. 1991;32:890–894
  23. Dhuna A, Pascual-Leone A, Langendorf F, et al. Epileptogenic properties of cocaine in humans. Neurotoxicology. 1991;12:621–626
  24. Madras BK, Fahey MA, Bergman J, et al. Effects of cocaine and related drugs in nonhuman primates (I. [3H]Cocaine binding sites in caudate-putamen). J Pharmacol Exp Ther. 1989;251:131–141
  25. Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press; 2006;
  26. Koehler SA, Ladham S, Rozin L, et al. The risk of body packing: a case of fatal cocaine overdose. Forensic Sci Int. 2005;151:81–84
  27. Hayes SN, Moyer TP, Morley D, et al. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am Heart J. 1991;121:1639–1648
  28. Derlet RW, Albertson TE. Flumazenil induced seizures and death in mixed cocaine-diazepam intoxications. Ann Emerg Med. 1994;23:494–498
  29. Núñez BD, Miao L, Klein MA, et al. Acute and chronic cocaine exposure can produce myocardial ischemia and infarction in Yucatan swine. J Cardiovasc Pharmacol. 1997;29:145–155
  30. Núñez BD, Miao L, Kuntz RE, et al. Cardiogenic shock induced by cocaine in swine with normal coronary arteries. Cardiovasc Res. 1994;28:105–111
  31. Núñez BD, Miao L, Wang Y, et al. Cocaine-induced microvascular spasm in Yucatan miniature swine (In vivo and in vitro evidence of spasm). Circ Res. 1994;74:281–290
  32. Wang SY, Núñez BD, Morgan JP, et al. Cocaine and the porcine coronary microcirculation: effects of chronic cocaine exposure and hypercholesterolemia. J cardiothorac Vasc Anesth. 1995;9:290–296
  33. Núñez BD, Miao L, Ross JN, et al. Effects of cocaine on carotid vascular reactivity in swine after balloon vascular injury. Stroke. 1994;25:631–638
  34. Tella SR, Korupolu GR, Schindler CW, et al. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats. J Pharmacol Exp Ther. 1992;262:936–946
  35. Spealman RD, Kelleher RT, Goldberg SR. Stereoselective behavioral effects of cocaine and a phenyltropane analog. J Pharmacol Exp Ther. 1983;225:509–514
  36. Balster RL, Carroll FI, Graham JH, et al. Potent substituted-3 beta-phenyltropane analogs of cocaine have cocaine-like discriminative stimulus effects. Drug Alcohol Depend. 1991;29:145–151

 Provide feedback on this article at the journal's Web site, www.annemergmed.com.

 Supervising editor: Stephen R. Thom, MD, PhD

 Author contributions: EMJ and JHW conceived the study and designed the experiments. EMJ, MGB, and ZDC performed the data collection and analysis. DN and RKS produced and purified the cocaine esterase used in this study. EMJ drafted the article, and all authors contributed to the revisions. EMJ and JHW take responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. This work was supported by grants from the United States Public Health Service DA021416 and T32 DA07268.

 Reprints not available from the authors.

 Publication date: Available online November 14, 2008.

PII: S0196-0644(08)01787-3

doi: 10.1016/j.annemergmed.2008.09.023

Annals of Emergency Medicine
Volume 54, Issue 3 , Pages 409-420 , September 2009